CTRI Number |
CTRI/2012/11/003127 [Registered on: 21/11/2012] Trial Registered Retrospectively |
Last Modified On: |
19/11/2012 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug |
Study Design |
Randomized, Parallel Group, Active Controlled Trial |
Public Title of Study
|
A clinical trial to study the effects of adapalene, benzoyl peroxide, and benzoyl peroxide-clindamycin combination in patients having pimples. |
Scientific Title of Study
|
A Randomized, open label, active controlled, parallel group trial to compare the safety and efficacy of adapalene, benzoyl peroxide, and benzoyl peroxide-clindamycin combination in patients with acne vulgaris. |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Anuradha Dubey |
Designation |
PG Student |
Affiliation |
Peoples College of Medical Sciences and Research Centre |
Address |
Department of Pharmacology, Peoples College of Medical Sciences and Research Centre, Bhanpur, Bhopal
Bhopal MADHYA PRADESH 462037 India |
Phone |
9926193059 |
Fax |
|
Email |
dranudubey999@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Hanmant Amane |
Designation |
Associate Professr |
Affiliation |
Peoples College of Medical Sciences and Research Centre |
Address |
Department of Pharmacology, Peoples College of Medical Sciences and Research Centre, Bhanpur, Bhopal
Bhopal MADHYA PRADESH 462037 India |
Phone |
8717955345 |
Fax |
|
Email |
drhsamane25@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Hanmant Amane |
Designation |
Associate Professr |
Affiliation |
Peoples College of Medical Sciences and Research Centre |
Address |
Department of Pharmacology, Peoples College of Medical Sciences and Research Centre, Bhanpur, Bhopal
Bhopal MADHYA PRADESH 462037 India |
Phone |
8717955345 |
Fax |
|
Email |
drhsamane25@gmail.com |
|
Source of Monetary or Material Support
|
Peoples college of medical sciences and research center |
|
Primary Sponsor
|
Name |
Peoples college of medical sciences |
Address |
Bhanpur Bhopal |
Type of Sponsor |
Private medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Hanmant Amane |
department of dermatology, PCMS |
Bhanpur Bhopal Bhopal MADHYA PRADESH |
8717955345
drhsamane25@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committee, Peoples college of medical sciences and research center |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
Mild to Moderate Acne vulgaris, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Adapalene |
0.1% thin film to be applied once daily at bed time for three months |
Comparator Agent |
Benzoyl peroxide |
2.5% thin film to be applied once daily at bed time for three months |
Comparator Agent |
Benzoyl peroxide and clindamycin combination |
2.5% and 1% thin film to be applied once daily at bed time for three months |
|
Inclusion Criteria
|
Age From |
12.00 Year(s) |
Age To |
30.00 Year(s) |
Gender |
Both |
Details |
1. Healthy males, and non-pregnant females, aged 12-30 years with a clinical diagnosis of mild-moderate acne vulgaris.
2. Presence of Non-inflammatory lesions (comedones).
3. Presence of mild to moderate inflammatory lesions like papules and pustules (Grades 1 and 2).
|
|
ExclusionCriteria |
Details |
1. Acne patients with ages below 12years, or above 30 years.
2. Pregnant and nursing females.
3. Presence of severe inflammatory lesions of acne like nodulo-cystic lesions (Grades 3 and 4).
4. Presence of any other skin condition that would interfere with the diagnosis and assessment of acne vulgaris, (eg-on the face-rosaceae, dermatitis).
5. Excessive facial hair (eg-beard) that would interfere with diagnosis or assessment of acne vulgaris.
6. History of hypersensitivity or allergy to these drugs.
7. Use of any other drug for the treatment of acne vulgaris within 2 months.
8. Patients on hormonal treatment.
9. Patient on drugs causing acne as a side effect.
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
On-site computer system |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
Acne severity index
Total acne lesion count |
Acne severity index and
Total acne lesion count will be assessed after 2 4 6 8 10 12 weeks. |
|
Secondary Outcome
|
Outcome |
TimePoints |
Acne severity index
Total acne lesion count |
12 weeks |
|
Target Sample Size
|
Total Sample Size="150" Sample Size from India="150"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 4 |
Date of First Enrollment (India)
|
15/11/2012 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Open to Recruitment |
Publication Details
|
Not Applicable |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
The present study is a randomized, open label, active controlled, parallel group trial comparing the efficacy and safety of Adapalene 0.1% , Benzoyl peroxide 2.5%, and Benzoyl peroxide 2.5% -Clindamycin 1% combination daily at bed time for 3 months in 150 patients of acne vulgaris. The study will be conducted in Peoples college of medical sciences and research center, Bhopal, India. The primary outcome measures are acne severity index and total acne lesion count. |